Skip to Main Content

Author Details

Steven B Bradfute
2003
91
31
PMIDPaper TitleJournal TitlePublished Year
36851776The Host Non-Coding RNA Response to Alphavirus Infection.2023
36436722The life cycle of the alphaviruses: From an antiviral perspective.Antiviral Research2023
37622664Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm <i>Riboviria</i>: kingdom <i>Orthornavirae</i>: phylum <i>Negarnaviricota</i>).J Gen Virol2023
37140960Viral persistence, reactivation, and mechanisms of long COVID.2023
36567023History and impact of the mouse-adapted Ebola virus model.2023
36567020Mouse models of Ebola virus tolerance and lethality: characterization of CD-1 mice infected with wild-type, guinea pig-adapted, or mouse-adapted virus.2023
37315110Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody.Sci Transl Med2023
36623351A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology.2023
36992369Pending Reorganization of <i>Hantaviridae</i> to Include Only Completely Sequenced Viruses: A Call to Action.Viruses2023
34374750Non-autophagy Role of Atg5 and NBR1 in Unconventional Secretion of IL-12 Prevents Gut Dysbiosis and Inflammation.2022
35458412Use of a Novel Detection Tool to Survey Orthohantaviruses in Wild-Caught Rodent Populations.Viruses2022
36305549Understanding host responses to equine encephalitis virus infection: implications for therapeutic development.Expert Review of Anti-Infective Therapy2022
35491994Elevated SARS-CoV-2 in peripheral blood and increased COVID-19 severity in American Indians/Alaska Natives.Exp Biol Med (Maywood)2022
35801557Immune Responses to Herpes Simplex Virus Infection: Implications for Vaccine Development.Journal of Infectious Diseases2022
364374282022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2022
35599623Healthy humans can be a source of antibodies countering COVID-19.Bioengineered2022
35294259Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.Science Translational Medicine2022
35215864Inactivation of Venezuelan Equine Encephalitis Virus Genome Using Two Methods.Viruses2022
34962451The discovery and development of novel treatment strategies for filoviruses.Expert Opinion on Drug Discovery2022
34650161Integrin activation is an essential component of SARS-CoV-2 infection.Scientific Reports2021
33545284Formulation of stabilizer-free, nontoxic PLGA and elastin-PLGA nanoparticle delivery systems.International Journal of Pharmaceutics2021
34232859Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells.eLife2021
34067345Anti-SARS-CoV-2 Activity of Surgical Masks Infused with Quaternary Ammonium Salts.Viruses2021
34219476COVID-19 global pandemic planning: Presence of SARS-CoV-2 fomites in a university hospital setting.Experimental Biology and Medicine2021
33948596SARS-COV-2 induced Diarrhea is inflammatory, Ca <sup>2+</sup> Dependent and involves activation of calcium activated Cl channels.bioRxiv2021
34312625Integrin activation is an essential component of SARS-CoV-2 infection.2021
33098417Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.journal of applied laboratory medicine, The2021
32985653The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication.Glycobiology2021
33342283COVID-19 global pandemic planning: Dry heat incubation and ambient temperature fail to consistently inactivate SARS-CoV-2 on N95 respirators.Experimental Biology and Medicine2021
34741801Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes.Cell2021
344638772021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2021
34452463Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease.Viruses2021
34451861RNA Phage VLP-Based Vaccine Platforms.Pharmaceuticals2021
34549977Tracing Transmission of Sin Nombre Virus and Discovery of Infection in Multiple Rodent Species.J Virol2021
32605027Ribosome Display Technology: Applications in Disease Diagnosis and Control.Antibodies2020
32252021Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection.iScience2020
32397762COVID-19 global pandemic planning: Decontamination and reuse processes for N95 respirators.Experimental Biology and Medicine2020
31932041The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccination.Antiviral Research2020
32653070The value of antimicrobial peptides in the age of resistance.Lancet Infect Dis2020
32817934Ambroxol and Ciprofloxacin Show Activity Against SARS-CoV2 in Vero E6 Cells at Clinically-Relevant Concentrations.2020
33330842Virtual and <i>In Vitro</i> Antiviral Screening Revive Therapeutic Drugs for COVID-19.ACS Pharmacol Transl Sci2020
32779705Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.J Infect Dis2020
32503232Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.Vaccines2020
328880502020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2020
31074409Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display.American Journal of Tropical Medicine and Hygiene2019
29627146Ebola virus vaccination and the longevity of total versus neutralising antibody response-is it enough?Lancet Infectious Diseases, The2018
30444865Ribosome display for the rapid generation of high-affinity Zika-neutralizing single-chain antibodies.PLoS ONE2018
30337177Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.Vaccine2018
27984785Comparison of N- and O-linked glycosylation patterns of ebolavirus glycoproteins.Virology2017
28606592Advances in Ebola virus vaccination.Lancet Infectious Diseases, The2017
  • 1 - 50 of 91

Recommended Authors

Collaborators

Co-authored papers 24
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 14
Co-authored papers 8
University of Pretoria
Co-authored papers 8
University of Texas Medical Branch
Co-authored papers 6
Co-authored papers 6
University of Pretoria
Co-authored papers 4
Centers for Disease Control and Prevention (CDC)
Co-authored papers 4
University of New Mexico
Co-authored papers 4
Boston University
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Institute of Virology, Philipps University Marburg
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Institute of Virology, Medical Center - University of Freiburg
Co-authored papers 4
Co-authored papers 3
Institute of Virology, Philipps University
Co-authored papers 3
University of Texas Medical Branch
Co-authored papers 3
Christchurch Hospital
Co-authored papers 2
Washington University School of Medicine at St. Louis
Co-authored papers 2
University of Cambridge
Co-authored papers 2
Institute of Virology, Philipps-University Marburg
Co-authored papers 2
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
University of Texas Medical Branch
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2